IMPACT Therapeutics Investors

15 investors on Angel Roster list IMPACT Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Early Stage Venture and the largest groups are based in China, the United States and Hong Kong.

Investors are matched on the company name in their portfolio, so companies that share the name IMPACT Therapeutics can appear together.

Investors listed
15
With verified email
40%
Most common stage
Early Stage Venture
Top location
China

Updated October 13, 2026 · How we compile this data

Top 15 IMPACT Therapeutics investors

The most complete profiles first. Showing 15 of 15.

  • Victor TongVerified

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Claire ChinVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Fei ChenVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Judith LiVerified

    Venture Capital · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Verified email available

  • Qiang XuVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Wei XuVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Yi ShiVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Verified email available

  • Dan Zabrowski

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Fang Yang

    Venture Capital, Private Equity Firm · China

    Early Stage VentureHealth CareInvestment ManagementChemicalLife Science

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Nick Pliam

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Weizhi (Aaron) Li

    Venture Capital, Private Equity Firm · China

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Y. Katherine Xu

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Jieyu Zou

    Venture Capital · China

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Ling Su

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Sam Isaly

    Angel/Individual, Investment Partner

    Health CareBiotechnologyTherapeuticsPharmaceuticals

    Portfolio: IMPACT Therapeutics

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many IMPACT Therapeutics investors are on Angel Roster?

Angel Roster lists 15 IMPACT Therapeutics investors. 6 of them (40%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (14), Private Equity Firms (6) and Angel Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do IMPACT Therapeutics investors invest in?

Among those that list a stage, the most common are Early Stage Venture (6).

Where are IMPACT Therapeutics investors based?

Most are based in China (9), the United States (4) and Hong Kong (1).

Which companies have IMPACT Therapeutics investors backed?

The most-backed portfolio companies among them are Terns Pharmaceuticals (14), ReadCoor (14), BCFoods (9), AnHeart Therapeutics (9) and EpimAb Biotherapeutics (9).

How do I contact IMPACT Therapeutics investors?

Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.